⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10024862 | 0.97 | TSHR (0.35) | — | |
| SCHEMBL11597204 | 0.97 | — | — | |
| SCHEMBL28905362 | 0.87 | TSHR (0.47) | — | |
| SCHEMBL18574556 | 0.80 | — | — | |
| SCHEMBL797619 | 0.80 | — | — | |
| SCHEMBL13180576 | 0.80 | — | — | |
| SCHEMBL13379346 | 0.80 | — | — | |
| SCHEMBL12961695 | 0.80 | — | — | |
| SCHEMBL9768351 | 0.79 | — | — | |
| SCHEMBL12657015 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170212037-A1 | COLORIMETRIC PLASMONIC NANOSENSOR FOR DOSIMETRY OF THERAPEUTIC LEVELS OF IONIZING RADIATION | BANNER HEALTH, AN ARIZONA NONPROFIT CORPORATION | 2017-07-27 | — | — | US | disclosed |
| EP-0750649-B1 | BRANCHED POLYOXAALKYL MACROMOLECULES, PROCESS FOR MAKING THEM AND THEIR USES | BRACCO IMAGING SPA (IT) | 2001-12-19 | — | — | EP | disclosed |
| US-5780644-A | BRANCHES AND CASCADES OF POLYOXYALKYLENE GLYCOLS; DRUG CARRIERS; CONTRAST AGENTS FOR MEDICAL IMAGING | DIBRA S.P.A. (IT) | 1998-07-14 | — | — | US | disclosed |
| EP-0750649-A1 | BRANCHED POLYOXAALKYL MACROMOLECULES, PROCESS FOR MAKING THEM AND THEIR USES | BRACCO S.p.A. (IT) | 1997-01-02 | — | — | EP | disclosed |
| WO-1995025763-A1 | BRANCHED POLYOXAALKYL MACROMOLECULES, PROCESS FOR MAKING THEM AND THEIR USES | BRACCO S.P.A. (IT) | 1995-09-28 | — | — | WO | disclosed |